(Reuters) -Elon Musk said on Wednesday he expects a wireless brain chip developed by his company Neuralink to begin human clinical trials in six months, after the company missed earlier timelines set by him.
The company is developing brain chip interfaces that it says could help disabled patients to move and communicate again, with Musk adding on Wednesday it will also target restoring vision.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
